Atossa Therapeutics declares CVR dividend
- Declared one stapled CVR per share outstanding as of Oct 19, 2026
- CVRs entitle holders to 25% of net proceeds from PRV monetization
- $50 million cap on total CVR payments
ATOS
ATOSSA THERAPEUTICS, INC. SEC filings
Every EDGAR filing for ATOSSA THERAPEUTICS, INC. (ATOS), newest first, with AI summaries and stories.
- Ticker
- ATOS
- CIK
- 1488039
- Sector
- Biotech and pharma
- Latest filing
- Oct 9
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 10-QATOSSA THERAPEUTICS, INC.ATOSLIVE 424B5ATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 4ATOSSA THERAPEUTICS, INC.ATOSLIVE Richard I Steinhart, insider filing for ATOS
Richard I Steinhart, reporting
4ATOSSA THERAPEUTICS, INC.ATOSLIVE 5 insider filings
Shu-Chih Chen, insider filing for ATOS
Show all 5
- 4Insider filing for ATOS
- 4Insider filing for ATOS
- 4Insider filing for ATOS
- 4Insider filing for ATOS
- 4Insider filing for ATOS
Shu-Chih Chen, reporting
8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 10-QATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 4ATOSSA THERAPEUTICS, INC.ATOSLIVE Steven C Quay, insider filing for ATOS
Steven C Quay, reporting
4ATOSSA THERAPEUTICS, INC.ATOSLIVE Mark James Daniel, insider filing for ATOS
Mark James Daniel, reporting
ARSATOSSA THERAPEUTICS, INC.ATOSLIVE DEF 14AATOSSA THERAPEUTICS, INC.ATOSLIVE 10-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE PRE 14AATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 424B5ATOSSA THERAPEUTICS, INC.ATOSLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B3Securities offering
8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 4/AATOSSA THERAPEUTICS, INC.ATOSLIVE Steven C Quay, insider filing for ATOS (amended)
Steven C Quay, reporting
8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 4ATOSSA THERAPEUTICS, INC.ATOSLIVE Steven C Quay, insider filing for ATOS
Steven C Quay, reporting
8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE DEF 14AATOSSA THERAPEUTICS, INC.ATOSLIVE PRE 14AATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 8-KATOSSA THERAPEUTICS, INC.ATOSLIVE 10-QATOSSA THERAPEUTICS, INC.ATOSLIVE